Skip to the main content.

Black and African Americans’ Connections to Parkinson’s Disease

OBSERVATIONAL STUDY

Case Studies

Here you can edit the background of the section

Key Takeaways

The Michael J. Fox Foundation engaged BBK Worldwide to assist in developing patient recruitment materials for the Black and African Americans’ Connections to Parkinson’s Disease (BLAAC PD) study. The study was being conducted as part of the Global Parkinson’s Genetics Program — an initiative focused on changing the landscape by deciphering the genetic architecture of Parkinson's disease in traditionally underserved populations.
 
The BLAAC PD study was recruiting 2,000 Black and African Americans with Parkinson’s Disease (including familial / sporadic Parkinson’s disease cases or individuals with atypical parkinsonism) and 3,000 healthy subjects from across North America. 

MJFF-PPMI-Parkinsons_Landingpage-Image

Challenges

African Americans are less likely to be diagnosed with Parkinson’s disease, more likely to have delays in diagnosis, and, once diagnosed, are undertreated when compared with white patients.

Longstanding issues of trust regarding clinical research among the Black and African American community created a barrier for engagement.

Parkinson’s disease research has not historically focused on the Black and African American community, therefore introducing the study opportunity required education about clinical trial participation in addition to study-specific information.

Solutions

Create patient-facing materials that present Black and African Americans as partners in research to increase interest in the GP2 BLAAC PD study.

Convey the value of participating in the study and how participants can help scientists learn more about genes linked to Parkinson’s disease.

Capitalize on the site’s existing relationships with patients by providing tools that support staff in connecting with potential participants about the study opportunity. 

Impact

Concepts were reviewed by an advisory board of patients and caregivers to ensure creative content resonated with patients.

The final creative materials leveraged the concept of “Leave Your Mark,” empowering those seeking to contribute to Parkinson’s disease research. 

Underrepresented-Icon-png

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Download the PDF version of this case study today:

Subscribe to stay connected

Share this page:

Familial Amyloid Polyneuropathy — Neurology and Gene Therapy — Phase 3

case-studies-icon Case Studies

October 12, 2021

Pediatric Spinal Muscular Atrophy — Neurology and Rare Disease — Phase 2

case-studies-icon Case Studies

December 13, 2021

Major Depressive Disorder — Mental Health — Pivotal Phase 3 Study

case-studies-icon Case Studies

February 5, 2022

BBK Worldwide, LLC
117 Kendrick St., Suite 600
Needham, MA 02494 United States

        Terms & Conditions  Privacy Policy

        © 2024 BBK Worldwide. BBK Worldwide is a Publicis Health company.

        Facebook LinkedIn YouTube
        Facebook LinkedIn YouTube

        Terms & Conditions  Privacy Policy

        © 2024 BBK Worldwide. BBK Worldwide is a Publicis Health company.